LungLife AI Inc, down 79% at 2.15p, 12-month range 1.77p-45.50p. The developer of clinical diagnostic solutions for lung cancer believes the best course of action is to propose an exit from AIM.
New funding from NSERC and UK Research and Innovation (UKRI) will advance several U of T Engineering projects related to quantum communication networks, quantum computing and more.